Cascallo M - Search Results

1

Antitumor therapy based on cellular competition.

Martinez-Quintanilla J, Cascallo M, Fillat C, Alemany R. Martinez-Quintanilla J, et al. Among authors: cascallo m. Hum Gene Ther. 2009 Jul;20(7):728-38. doi: 10.1089/hum.2008.144. Hum Gene Ther. 2009. PMID: 19281300

2

Coagulation factors determine tumor transduction in vivo.

Gimenez-Alejandre M, Cascallo M, Bayo-Puxan N, Alemany R. Gimenez-Alejandre M, et al. Among authors: cascallo m. Hum Gene Ther. 2008 Dec;19(12):1415-9. doi: 10.1089/hum.2008.053. Hum Gene Ther. 2008. PMID: 18795826

3

Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapy.

Martinez-Quintanilla J, Cascallo M, Gros A, Fillat C, Alemany R. Martinez-Quintanilla J, et al. Among authors: cascallo m. Mol Cancer Ther. 2009 Nov;8(11):3098-107. doi: 10.1158/1535-7163.MCT-09-0350. Epub 2009 Nov 3. Mol Cancer Ther. 2009. PMID: 19887556

4

Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses.

Rojas JJ, Guedan S, Searle PF, Martinez-Quintanilla J, Gil-Hoyos R, Alcayaga-Miranda F, Cascallo M, Alemany R. Rojas JJ, et al. Among authors: cascallo m. Mol Ther. 2010 Nov;18(11):1960-71. doi: 10.1038/mt.2010.173. Epub 2010 Aug 31. Mol Ther. 2010. PMID: 20808288 Free PMC article.

5

Adeno-associated virus enhances wild-type and oncolytic adenovirus spread.

Laborda E, Puig-Saus C, Cascalló M, Chillón M, Alemany R. Laborda E, et al. Among authors: cascallo m. Hum Gene Ther Methods. 2013 Dec;24(6):372-80. doi: 10.1089/hgtb.2013.124. Epub 2013 Oct 8. Hum Gene Ther Methods. 2013. PMID: 24020980 Free PMC article.

6

Osteosarcoma cells as carriers to allow antitumor activity of canine oncolytic adenovirus in the presence of neutralizing antibodies.

Alcayaga-Miranda F, Cascallo M, Rojas JJ, Pastor J, Alemany R. Alcayaga-Miranda F, et al. Among authors: cascallo m. Cancer Gene Ther. 2010 Nov;17(11):792-802. doi: 10.1038/cgt.2010.36. Epub 2010 Jul 30. Cancer Gene Ther. 2010. PMID: 20671769

7

Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD.

Rojas JJ, Gimenez-Alejandre M, Gil-Hoyos R, Cascallo M, Alemany R. Rojas JJ, et al. Among authors: cascallo m. Gene Ther. 2012 Apr;19(4):453-7. doi: 10.1038/gt.2011.106. Epub 2011 Jul 21. Gene Ther. 2012. PMID: 21776023

8

Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers.

Puig-Saus C, Gros A, Alemany R, Cascalló M. Puig-Saus C, et al. Among authors: cascallo m. Mol Ther. 2012 Jan;20(1):54-62. doi: 10.1038/mt.2011.159. Epub 2011 Aug 23. Mol Ther. 2012. PMID: 21863000 Free PMC article.

9

Adenovirus-mediated gene transfer to tumor cells.

Cascalló M, Alemany R. Cascalló M, et al. Methods Mol Biol. 2004;246:121-38. doi: 10.1385/1-59259-650-9:121. Methods Mol Biol. 2004. PMID: 14970588

10

Deletion of VAI and VAII RNA genes in the design of oncolytic adenoviruses.

Cascallo M, Gros A, Bayo N, Serrano T, Capella G, Alemany R. Cascallo M, et al. Hum Gene Ther. 2006 Sep;17(9):929-40. doi: 10.1089/hum.2006.17.929. Hum Gene Ther. 2006. PMID: 16972761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters